Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer

Research output: Contribution to journalArticleResearchpeer review

Authors

  • J. Matthias Von Der Schulenburg
  • Anne Prenzler
  • Willemien Schurer

External Research Organisations

  • London School of Economics and Political Science
View graph of relations

Details

Original languageEnglish
Pages (from-to)S21-S26
JournalEuropean Journal of Health Economics
Volume10
Issue numberSUPPL. 1
Early online date10 Dec 2009
Publication statusPublished - Jan 2010

Abstract

This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.

Keywords

    Cancer management, Colorectal cancer, CRC, Germany, Health policy

ASJC Scopus subject areas

Sustainable Development Goals

Cite this

Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer. / Von Der Schulenburg, J. Matthias; Prenzler, Anne; Schurer, Willemien.
In: European Journal of Health Economics, Vol. 10, No. SUPPL. 1, 01.2010, p. S21-S26.

Research output: Contribution to journalArticleResearchpeer review

Von Der Schulenburg JM, Prenzler A, Schurer W. Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer. European Journal of Health Economics. 2010 Jan;10(SUPPL. 1):S21-S26. Epub 2009 Dec 10. doi: 10.1007/s10198-009-0194-x
Von Der Schulenburg, J. Matthias ; Prenzler, Anne ; Schurer, Willemien. / Cancer management and reimbursement aspects in Germany : an overview demonstrated by the case of colorectal cancer. In: European Journal of Health Economics. 2010 ; Vol. 10, No. SUPPL. 1. pp. S21-S26.
Download
@article{c97a4bfc095e4e3d9322d804d2a954c8,
title = "Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer",
abstract = "This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.",
keywords = "Cancer management, Colorectal cancer, CRC, Germany, Health policy",
author = "{Von Der Schulenburg}, {J. Matthias} and Anne Prenzler and Willemien Schurer",
year = "2010",
month = jan,
doi = "10.1007/s10198-009-0194-x",
language = "English",
volume = "10",
pages = "S21--S26",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer Verlag",
number = "SUPPL. 1",

}

Download

TY - JOUR

T1 - Cancer management and reimbursement aspects in Germany

T2 - an overview demonstrated by the case of colorectal cancer

AU - Von Der Schulenburg, J. Matthias

AU - Prenzler, Anne

AU - Schurer, Willemien

PY - 2010/1

Y1 - 2010/1

N2 - This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.

AB - This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.

KW - Cancer management

KW - Colorectal cancer

KW - CRC

KW - Germany

KW - Health policy

UR - http://www.scopus.com/inward/record.url?scp=76649126203&partnerID=8YFLogxK

U2 - 10.1007/s10198-009-0194-x

DO - 10.1007/s10198-009-0194-x

M3 - Article

AN - SCOPUS:76649126203

VL - 10

SP - S21-S26

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

IS - SUPPL. 1

ER -